Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Searles

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The next phase of real-world clinical experience with alefacept: the AWARE-2 registryGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE studyIan Landells, Gordon Searles, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Pathogenesis of psoriasis and current challengesAditya K Gupta, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The AWARE study: methodology and baseline characteristicsRobert Bissonnette, Gordon Searles, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Update on alefacept safetyDenise Wexler, Gordon Searles, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque PsoriasisWayne Gulliver, Charles Lynde, Jan P Dutz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The next phase of real-world clinical experience with alefacept: the AWARE-2 registryGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE studyIan Landells, Gordon Searles, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Pathogenesis of psoriasis and current challengesAditya K Gupta, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
The AWARE study: methodology and baseline characteristicsRobert Bissonnette, Gordon Searles, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Update on alefacept safetyDenise Wexler, Gordon Searles, Ian Landells, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque PsoriasisWayne Gulliver, Charles Lynde, Jan P Dutz, et al.
Pageof 1